S
Sagimet Biosciences Inc.
SGMT · NASDAQ · Healthcare · 344M
Closing price
$8.93
+0.11% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.6×
Enterprise value / EBITDAEV/EBITDA
-5.0×
Free cash flow yieldFCF yield
-15.8%
Return on equityROE
-45.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.7×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.